Relic Technologies Ltd

RELICTEC

Watchlist

AI Mode

‌

Market Cap

₹ 41 Cr

P/E

—

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

REASONABLE

Growth

STABLE

Profitability

LOW MARGIN

Technicals

Bullish

Risk

LOW RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Relic Technologies Ltd, founded in 1991, primarily operates in the share broking business and is a member of the National Stock Exchange.

The company is planning to diversify into pharmaceutical activities and considers a name change to Relic Life Science Ltd.

This strategic shift indicates potential expansion into the pharmaceutical industry, which could diversify revenue streams and reduce dependency on share broking.

The planned name change reflects a clear strategic intent to align corporate identity with its new business focus.

As an NSE member with institutional clients, Relic has a solid foundation which can support its diversification efforts.

Sector

Stock/ Commodity Brokers

Industry

Securities/Commodities Trading Services

Market Cap

41 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

41.1

PEG Ratio

—

P/B Ratio

2.8

52W High

93.96

52W Low

19.00

Sales CAGR

24.39%

-1.17%

10.96%

10Y

7.28%

Profit CAGR

-65.56%

—

10Y

—

ROE

TTM

-18.29%

-10.57%

-4.12%

10Y

0.13%

ROCE

TTM

-20.39%

-9.33%

-2.84%

10Y

1.94%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BRIDGESE	13.51	53 Cr	48.75	11.03	0.00	25.22	36.66	17.67
NAM	95.95	52 Cr	218.07	4.43	0.00	2.02	2.86	1.95
AJCON	8.15	49 Cr	—	1.89	0.00	-0.17	2.30	-0.05
RELICTEC	80.00	41 Cr	—	2.76	0.00	-18.29	-20.39	-29.88
WALCHPF	133.00	39 Cr	13.94	1.32	0.75	9.46	12.27	7.63
KHANDSE	22.03	34 Cr	—	1.18	0.00	-6.51	-2.14	-3.60
VERTEX	3.85	28 Cr	—	3.43	0.00	-17.94	-6.82	-4.59

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	0.43	0.30	0.42	0.38	0.41	0.63	0.47	0.47	1.28	0.60
Expenses	0.52	0.32	0.45	1.03	0.47	0.46	1.43	0.78	2.71	1.46
Interest	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.05	0.03	0.03
Financing Profit	-0.09	-0.03	-0.04	-0.66	-0.07	0.16	-0.97	-0.36	-1.46	-0.89
Financing Margin %	-20.93	-10.00	-9.52	-173.68	-17.07	25.40	-206.38	-76.60	-114.06	-148.33
Other Income	0.03	0.03	0.03	0.03	0.02	0.04	0.03	-0.02	-2.14	0.20
Depreciation	0.04	0.05	0.05	0.04	0.05	0.06	0.06	0.13	0.08	0.08
Profit Before Tax	-0.11	-0.05	-0.06	-0.67	-0.11	0.14	-1.00	-0.51	-3.68	-0.77
Tax %	0.00	0.00	0.00	-1.49	0.00	0.00	0.00	-3.92	0.00	119.48
Net Profit	-0.11	-0.05	-0.06	-0.67	-0.11	0.14	-1.00	-0.53	-3.68	0.16
EPS in Rs	-0.21	-0.10	-0.10	-1.27	-0.20	0.28	-1.94	-1.02	-7.09	0.29
Gross NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net NPA %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Revenue	0.84	1.15	2.24	0.99	1.31	1.72	1.45	1.53	1.98	2.85
Expenses	0.66	0.74	0.77	0.72	0.86	1.17	1.10	2.33	3.15	5.38
Interest	0.02	0.02	0.01	0.01	0.00	0.00	0.00	0.02	0.07	0.10
Financing Profit	0.17	0.40	1.46	0.26	0.45	0.55	0.35	-0.82	-1.24	-2.63
Financing Margin %	19.59	34.52	65.06	26.19	34.33	31.79	24.07	-53.37	-62.86	-92.28
Other Income	0.05	0.05	0.04	0.06	0.08	0.11	0.11	0.11	0.07	-2.09
Depreciation	0.16	0.16	0.13	0.12	0.06	0.10	0.13	0.18	0.30	0.33
Profit Before Tax	0.05	0.28	1.37	0.20	0.47	0.56	0.34	-0.89	-1.47	-5.05
Tax %	33.69	32.83	29.14	22.60	17.41	21.92	31.87	-0.64	-1.18	-0.40
Net Profit	0.01	0.19	0.97	0.16	0.39	0.43	0.23	-0.90	-1.49	-5.07
EPS in Rs	—	—	2.16	0.29	0.75	0.96	0.37	-1.68	-2.88	-9.76
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.60	3.60	3.60	3.60	3.60	3.60	3.60	3.60	3.60	3.60
Reserves	0.08	0.09	0.23	1.20	1.26	1.67	2.17	2.36	1.49	6.24
Borrowings	0.91	0.81	0.73	0.38	0.18	0.02	0.00	0.00	0.35	1.51
Other Liabilities	0.20	0.20	0.27	0.22	0.16	0.21	0.19	0.30	0.15	1.22
Total Liabilities	4.79	4.70	4.84	5.40	5.20	5.50	5.96	6.26	5.58	13
Fixed Assets	0.84	0.70	0.66	0.53	0.42	0.36	0.49	0.62	0.99	3.53
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.02
Other Assets	3.95	3.94	4.12	4.81	4.72	5.07	5.41	5.58	4.53	9.02
Total Assets	4.79	4.70	4.84	5.40	5.20	5.50	5.96	6.26	5.58	13

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.25	0.17	0.14	1.77	-0.43	0.06	0.16	0.16	0.23	-0.37
Cash from Investing Activity	0.04	0.01	-0.07	0.11	0.06	0.07	0.08	-0.14	-0.47	1.66
Cash from Financing Activity	-0.31	-0.06	-0.09	-0.36	-0.21	-0.16	-0.02	-0.00	0.33	4.43
Net Cash Flow	-0.02	0.12	-0.02	1.52	-0.58	-0.03	0.22	0.02	0.09	5.73

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	May 2025	Jun 2025	Sep 2025
Promoters	66.22%	66.22%	66.22%	66.22%	66.22%	66.22%	66.22%	66.22%	66.60%	46.55%	46.55%	46.55%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%
Public	33.75%	33.75%	33.75%	33.75%	33.75%	33.75%	33.75%	33.75%	33.38%	53.43%	53.43%	53.43%
Total Shareholders	1,538	1,574	1,692	1,766	1,913	1,988	2,123	2,188	2,092	2,084	2,079	2,073

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Mar 25, 2025	Multiplier share & stock advi...	Bulk	Sell	67.49	0.19 Cr	28,825	0.55
Nov 21, 2024	Smitha polineni	Bulk	Buy	17.82	0.04 Cr	20,000	0.38
Nov 18, 2024	Rekha mahesh jain	Bulk	Buy	14.31	0.03 Cr	20,500	0.39
Nov 18, 2024	Shri mahesh dhudchand jain	Bulk	Sell	14.25	0.03 Cr	20,477	0.39

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Change in Office

2 days ago

Change in Registered Office Address

Relic Technologies Limited announces the shifting of its registered office to a new address in Mumbai, effective January 1, 2026.

Change in Directors

2 days ago

Change in Management - Appointment of Director

Appointment of Mrs. Radhika Shriram as Additional Non-Executive Non-Independent Director effective December 13, 2025.

Corporate Action

2 days ago

Allotment of Shares Following Warrant Conversion

Allotment of 4,41,164 equity shares completed upon the conversion of warrants issued on a preferential basis.

Board Meeting Outcome

2 days ago

Outcome of Board Meeting on December 13, 2025

The Board of Directors approved the shift of the registered office, appointed a new secretarial auditor, allotted shares upon warrant conversion, and initiated an Employee Stock Option Plan, among other decisions.

Board Meeting Outcome

6 days ago

Board Meeting for Employee Stock Option Scheme

Relic Technologies Ltd will hold a board meeting on December 13, 2025, to discuss the approval of an Employee Stock Option Scheme.

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BRIDGESE	13.51	53 Cr	48.75	11.03	0.00	25.22	36.66	17.67
NAM	95.95	52 Cr	218.07	4.43	0.00	2.02	2.86	1.95
AJCON	8.15	49 Cr	—	1.89	0.00	-0.17	2.30	-0.05
RELICTEC	80.00	41 Cr	—	2.76	0.00	-18.29	-20.39	-29.88
WALCHPF	133.00	39 Cr	13.94	1.32	0.75	9.46	12.27	7.63
KHANDSE	22.03	34 Cr	—	1.18	0.00	-6.51	-2.14	-3.60
VERTEX	3.85	28 Cr	—	3.43	0.00	-17.94	-6.82	-4.59

Overview

Detailed Summary

Relic Technologies Ltd, founded in 1991, primarily operates in the share broking business and is a member of the National Stock Exchange.

The company is planning to diversify into pharmaceutical activities and considers a name change to Relic Life Science Ltd.

This strategic shift indicates potential expansion into the pharmaceutical industry, which could diversify revenue streams and reduce dependency on share broking.

The planned name change reflects a clear strategic intent to align corporate identity with its new business focus.

As an NSE member with institutional clients, Relic has a solid foundation which can support its diversification efforts.

Sector

Stock/ Commodity Brokers

Industry

Securities/Commodities Trading Services

Market Cap

41 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

41.1

PEG Ratio

—

P/B Ratio

2.8

52W High

93.96

52W Low

19.00

Sales CAGR

24.39%

-1.17%

10.96%

10Y

7.28%

Profit CAGR

-65.56%

—

10Y

—

ROE

TTM

-18.29%

-10.57%

-4.12%

10Y

0.13%

ROCE

TTM

-20.39%

-9.33%

-2.84%

10Y

1.94%